Oral Probiotic Delivering GLP-1 Restores Pancreatic Function and Gut Barrier in Diabetic Mice
Recombinant L. lactis secreting GLP-1 analogue restored pancreatic β-cell mass, improved insulin secretion, repaired gut barrier, and modulated microbiota in T2D mice through oral delivery.
Quick Facts
What This Study Found
Recombinant L. lactis secreting GLP-1 analogue: restored β-cell mass and insulin secretion, improved glucose tolerance, repaired gut barrier (tight junctions), and beneficially modulated gut microbiota in T2D mice.
Key Numbers
How They Did This
Engineering of L. lactis for GLP-1 analogue secretion, oral administration to T2D mice, glucose tolerance testing, pancreatic histology/β-cell assessment, gut barrier integrity markers, and microbiota analysis.
Why This Research Matters
Injectable GLP-1 drugs are expensive and inconvenient. A probiotic delivering GLP-1 orally could democratize access to this transformative therapy.
The Bigger Picture
Probiotic-delivered peptide therapy represents a fundamentally new drug delivery paradigm — living factories producing medicine in the gut.
What This Study Doesn't Tell Us
Mouse model. GLP-1 levels from probiotic delivery may be lower than injectable. Long-term colonization and consistent GLP-1 production not guaranteed.
Questions This Raises
- ?Could this probiotic replace injectable GLP-1 drugs in humans?
- ?How long does the probiotic colonize and produce GLP-1?
- ?Would this approach work for other therapeutic peptides?
Trust & Context
- Key Stat:
- Living GLP-1 factory An engineered probiotic bacteria produces and delivers GLP-1 directly in the gut — potentially replacing expensive injectable drugs with an oral probiotic
- Evidence Grade:
- Preclinical with comprehensive mechanistic validation. Novel delivery platform.
- Study Age:
- Published in 2025.
- Original Title:
- Oral delivery of GLP-1 analogues by recombinant Lactococcus lactis restores pancreatic islet structure through intestinal mucosal absorption in diabetic mice.
- Published In:
- EBioMedicine, 124, 106141 (2026)
- Authors:
- Huang, Yuanjian(2), Lin, Xuancai, Deng, Min, Tang, Yanqing, Li, Simin, Xu, Binyan, Zeng, Weixing, Chen, Zerong, Hou, Xufeng, Lin, Ziqing, Meng, Xiaojing, Bai, Yang, Fan, Hongying, Zeng, Weisen
- Database ID:
- RPEP-15331
Evidence Hierarchy
Frequently Asked Questions
Could a probiotic replace GLP-1 injections?
In mice, an engineered probiotic producing GLP-1 in the gut improved diabetes, restored pancreatic cells, and fixed gut barrier — all from oral delivery. Human translation is the next challenge.
How does a probiotic deliver a drug?
The bacteria are genetically programmed to produce and secrete the GLP-1 peptide as they colonize the gut. They become tiny drug factories living inside the intestine.
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-15331APA
Huang, Yuanjian; Lin, Xuancai; Deng, Min; Tang, Yanqing; Li, Simin; Xu, Binyan; Zeng, Weixing; Chen, Zerong; Hou, Xufeng; Lin, Ziqing; Meng, Xiaojing; Bai, Yang; Fan, Hongying; Zeng, Weisen. (2026). Oral delivery of GLP-1 analogues by recombinant Lactococcus lactis restores pancreatic islet structure through intestinal mucosal absorption in diabetic mice.. EBioMedicine, 124, 106141. https://doi.org/10.1016/j.ebiom.2026.106141
MLA
Huang, Yuanjian, et al. "Oral delivery of GLP-1 analogues by recombinant Lactococcus lactis restores pancreatic islet structure through intestinal mucosal absorption in diabetic mice.." EBioMedicine, 2026. https://doi.org/10.1016/j.ebiom.2026.106141
RethinkPeptides
RethinkPeptides Research Database. "Oral delivery of GLP-1 analogues by recombinant Lactococcus ..." RPEP-15331. Retrieved from https://rethinkpeptides.com/research/huang-2026-oral-delivery-of-glp1
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.